Clinical Trial Update: Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy [Phase 3]

View source ↗

Summary

Open-label long-term Phase 3 study of adjunctive brivaracetam in pediatric epilepsy completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: UCB Pharma SA | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2022-08-29